Nuvectis Pharma | Investor Presentation Deck | 25 slides · page 8 of 25
The slide presents experimental evidence (Western blot) supporting the mechanism of action for NXP800 in ARID1a-deficient cancer cells.
Pitch deck · solution · present_solution · dense density
Slide locked Sign in to view
Slide schematic 5/5
image 1/1 list 1/1 paragraph 1/1 source-note 1/1 title 1/1
Components 5
screenshot bullet paragraph source-note headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.